中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
11期
448
,共1页
大肠癌%小鼠%中药干预%加味痛泻要方
大腸癌%小鼠%中藥榦預%加味痛瀉要方
대장암%소서%중약간예%가미통사요방
Colorectal cancer%Mice%Traditional Chinese medicine intervention%Add to the favor Yaofang reducing pain
目的探究大肠癌动物模型的建立及中药(加味痛泻要方)的干预作用.方法将100只小鼠作为研究对象,分为四组(加味痛泻要方剂量高中低三组+对照组),初期给药(DMH)诱发小鼠大肠癌,后采用免疫组化法对四组小鼠突变型P53蛋白表达进行观察,同时给予中药进行后期干预并做好观察记录.结果加味痛泻要方组发癌率明显低于对照组,并且中药干预能明显降低突变型P53蛋白表达.结论中药干预作用明显,对防治大肠癌疗效突出.
目的探究大腸癌動物模型的建立及中藥(加味痛瀉要方)的榦預作用.方法將100隻小鼠作為研究對象,分為四組(加味痛瀉要方劑量高中低三組+對照組),初期給藥(DMH)誘髮小鼠大腸癌,後採用免疫組化法對四組小鼠突變型P53蛋白錶達進行觀察,同時給予中藥進行後期榦預併做好觀察記錄.結果加味痛瀉要方組髮癌率明顯低于對照組,併且中藥榦預能明顯降低突變型P53蛋白錶達.結論中藥榦預作用明顯,對防治大腸癌療效突齣.
목적탐구대장암동물모형적건립급중약(가미통사요방)적간예작용.방법장100지소서작위연구대상,분위사조(가미통사요방제량고중저삼조+대조조),초기급약(DMH)유발소서대장암,후채용면역조화법대사조소서돌변형P53단백표체진행관찰,동시급여중약진행후기간예병주호관찰기록.결과가미통사요방조발암솔명현저우대조조,병차중약간예능명현강저돌변형P53단백표체.결론중약간예작용명현,대방치대장암료효돌출.
Objective To explore the establishment of animal model for colorectal cancer and the intervention effect of traditional chinese medicine (favored pain diarrhea Yaofang). Methods 100 mice as the research object, divided into four groups (favored pain diarrhea Yaofang dose professinally three groups and control group), initial dose (DMH) bath after colorectal cancer in mice induced by immunohistochemical method, four mice mutant P53 protein expression observation, at the same time give chinese medicine for later intervention and make observation record. Results Flavored pain diarrhea Yaofang group hair cancer rate was signifcantly lower than the control group, and traditional chinese medicine intervention can signifcantly reduce the mutant P53 protein expression. Conclusion Chinese medicine intervention has an obvious effect in the prevention of colorectal cancer, curative effect prominent.